Company Filing History:
Years Active: 2022-2024
Title: Innovations in Chemotherapy Prediction by Marsel Scheer
Introduction
Marsel Scheer is an accomplished inventor based in Salt Lake City, Utah. He has made significant contributions to the field of oncology through his innovative methods for predicting chemotherapy benefits. With a total of two patents to his name, Scheer's work focuses on enhancing treatment decisions for cancer patients.
Latest Patents
Marsel Scheer's latest patents revolve around a method of using biomarkers and clinical variables for predicting chemotherapy benefit. This invention provides methods for predicting chemotherapy benefit based on the expression analysis of biomarkers, such as RNA biomarker transcription analysis, taken from a tumor sample. The biomarker expression data can be combined with clinical variables, including tumor size and nodal status, to generate a profile that predicts the benefit of including chemotherapy as a treatment decision.
Career Highlights
Throughout his career, Marsel Scheer has worked with notable companies in the biotechnology sector, including Myriad Genetics, Inc. and Myriad International GmbH. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer treatment.
Collaborations
Marsel has collaborated with talented individuals in his field, including Alexander Gutin and Julia Reid. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Marsel Scheer's contributions to the field of oncology through his innovative patents demonstrate his commitment to improving cancer treatment outcomes. His work in predicting chemotherapy benefits is a significant step forward in personalized medicine.